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Dental workers in front-line of 
COVID-19: an in silico evaluation 
targeting their prevention
SARS-CoV-2 has high human-human transmission rate. The aerosols 
and saliva droplets are the main contamination source. Thus, it is crucial to 
point out that dental practitioners become a high-risk group of contagion 
by SARS-CoV-2. Based on this, protocols have been recommended to avoid 
cross-contamination during dental care; however, appropriate evidence has 
not yet been established. Objective: Our study sought to make a screening, 
by in silico analysis, of the potential of mouth rinses used in dental practices 
to prevent the dental workers' contamination by SARS-CoV-2. Methodology: 
Multiple sequence comparisons and construction of the phylogenetic tree were 
conducted using the FASTA code. Therefore, molecular docking investigation 
between SARS-CoV-2 proteins (Main Protease, Spike Glycoprotein, Non-
structure Protein, and Papain-like Protease) and molecules used in dental 
practices (chlorhexidine digluconate, hydrogen peroxide, cetylpyridinium 
chloride, povidone-iodine, gallic acid, β-cyclodextrin, catechin, and quercetin) 
was performed using AutoDock Vina. Moreover, 2D interactions of the complex 
protein-ligand structure were analyzed by Ligplot+. Results: The obtained 
results showed a remarkable affinity between SARS-CoV-2 proteins and all 
tested compounds. The chlorhexidine digluconate, catechin, and quercetin 
presented a higher affinity with SARS-CoV-2. Conclusions: The overall results 
allowed us to suggest that chlorhexidine is the most suitable active compound 
in reducing the SARS-CoV-2 salivary load due to its better binding energy. 
However, in vivo studies should be conducted to confirm their clinical use.
Keywords: Molecular docking simulation. Severe acute respiratory 
syndrome-related coronavirus. Practice management, Dental. Containment 
of biohazards.
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Introduction
The coronavirus disease 2019 (COVID-19) outbreak 
has drawn attention worldwide since its first identified 
case in Wuhan – China.1 This infectious disease, caused 
by the Severe Acute Respiratory Syndrome coronavirus 
(SARS-CoV-2), has spread globally and infected 
millions of people, leading thousands of individuals 
to death.2 The SARS-CoV-2 has high human-human 
transmissibility, and the saliva plays an essential role 
in it. Through the saliva droplets/aerosols inhalation or 
ingestion from infected people, health people may fall 
ill.3,4 Based on this rationale, asymptomatic patients 
also are considered a transmission vector, since they 
are freely carrying out their activities and endangering 
the population’s health.5 
Salivary glands and saliva are the main reservoirs 
to SARS-CoV-2 due to the high-affinity with the 
host-cell receptor angiotensin-converting enzyme II 
(ACE2), also found in salivary glands.6,7 Then, dental 
practitioners can be considered a high-risk group of 
contagion by SARS-CoV-2 due to their exposure to 
aerosols-generated procedures during dental care.8,9 
Moreover, a lack of evidence regarding what to do as 
a pre-procedural protocol to avoid SARS-CoV-2 cross-
infection is worrying. It should be resolved to offer 
more protection to dental workers.
Regarding this issue, some protocols have been 
recommended worldwide to avoid SARS-CoV-2 
dissemination during dental care. Based on this, mouth 
rinses with hydrogen peroxide, povidone-iodine, or 
chlorhexidine are used before any dental procedure.10 
However, once these suggestions have inadequate 
scientific support,11 appropriate evidence must be 
produced to understand the possible mechanism 
of action of these compounds. Additionally, clinical 
studies involving drug testing require time and involve 
risks for both research groups and researchers.12
In this context, in silico analyses play a fundamental 
role in simulating molecular processes to support 
validation studies between molecular and cellular 
processes.13 Among in silico analyses, the docking 
studies can be emphasized, which evaluate protein-
ligand complexes through a series of algorithms to 
generate scoring functions. Thus, these analyses can 
predict the biological effects of chemical compounds 
due to their ability to interact with proteins responsible 
for the virulence present in the surface.14 Therefore, 
the fastest scenario to test existing drugs on the SARS-
CoV-2 proteins (such as Main or Papain-like proteases, 
Spike glycoprotein, and non-structured proteins) is 
the in silico analysis, which is a robust approach to 
provide remarkable results. Thus, it could propose 
initial therapeutic strategies to prevent SARS-CoV-2 
contamination by dental workers.15
Then, our study aimed at providing preliminary 
data, using computational tools, of the therapeutic 
potential of mouth rinses, widely used in dentistry 
practices, to prevent the contamination of dental 
workers by SARS-CoV-2 during dental procedures. 
The absence of interaction between the SARS-CoV-2 
proteins and mouth rinses’ compounds was considered 
the null hypothesis.
Methodology
Retrieval of proteins sequences
The crystal structures and FASTA code of SARS-
CoV-2 proteins were obtained from the Research 
Collaboratory for Structural Bioinformatics Protein 
Data Bank – RCSB PDB (RRID: SCR_012820). 
Therefore, four different SARS-CoV-2 proteins groups 
[Main Protease – Mpro (6LU7, 6Y2E, 6Y84, 6YB7), Spike 
glycoprotein (6LVN, 6VSB, 6VXX, 6VYB), Non-structure 
Protein – NSP (6YHU, 6W4B, 6W4H, 6W37, 6WEY, 
6WIQ, 6WIJ), and Papain-like Protease (6W9C)] were 
selected as molecular targets. 
Sequence alignment, multiple sequence 
comparisons, and construction of the 
phylogenetic tree
Multiple sequence comparisons of proteins from 
SARS-CoV-2 was conducted using a Constraint-based 
Multiple Alignment Tool (COBALT, RRID: SCR_004152) 
through the FASTA code, which allowed to construct 
the phylogenetic tree by using the neighbor-joining 
method based on the alignment sequences.
Ligand selection and structure preparation 
Eight compounds were selected for in silico 
analyses: five substances commercially used as mouth 
rinses/mouthwashes [chlorhexidine digluconate – 
CHX (C34H54Cl2N10O14 – PubChem CID: 9552081), 
hydrogen peroxide – HP (H2O2 – PubChem CID: 784), 
cetylpyridinium chloride – CCP (C21H38ClN – PubChem 
CID: 31239), povidone-iodine – PVPI (C6H9I2NO – 
PubChem CID: 410087)] and three antimicrobial 
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compounds [gallic acid – GA (C7H6O5 – PubChem CID: 
370), β-cyclodextrin – BCD (C42H70O35 – PubChem CID: 
444041), catechin – CAT (C15H14O6 – PubChem CID: 
9064), quercetin – QTN (C15H10O7 – CID: 5280343)].
The 2D structures were retrieved from the National 
Center for Biotechnology Information (NCBI) chemical 
structure library (PubChem, RRID: SCR_004284). The 
files were imported in 2D SDF format and converted 
to 3D Protein Data Bank format (.pdb) by the Open 
Babel (RRID: SCR_014920). 
 The ligand’ rotatable bonds were defined using 
AutoDock, and the structures were saved as pdbqt 
files for the use in the docking studies.
SARS-CoV-2 proteins preparation
The AutoDock (RRID: SCR_012746) was used 
to delete repeated chains, heteroatoms, and water 
molecules, add polar hydrogens atoms, and add the 
charge atoms to the protein structure. Gasteiger 
charges were computed, and the structure was saved 
as a pdbqt file for the docking studies.
Molecular docking procedure
The 3D grids were created by the Autogrid algorithm 
to generate the grid parameter files (Autogrid, RRID: 
SCR_015982). Each grid map was set to the center of 
the Chain A. Docking parameters were set according to 
the protein (Table 1), and all analyses were conducted 
with “exhaustiveness = 8”.
Molecular docking was conducted using AutoDock 
Vina (RRID: SCR_011958), and the best ligand/protein 
model was identified based on the binding energy 
(ΔG – kcal/mol).16
Docking visualization
The results were viewed on UCSF Chimera 1.14 
(RRID: SCR_004097). Only one protein from each 
group was selected for the visualization. The 2D 
interactions of the complex protein-ligand structure, 
including hydrogen bonds and the bond lengths, were 
analyzed by Ligplot+ (RRID: SCR_018249) for the 
high-affinity bindings.17
Results 
Multiple sequence comparisons and construction 
of the phylogenetic tree
Sequence alignment and multiple sequence 
comparisons of the studied proteins from SARS-CoV-2 
(Figure 1) allowed observing their similarity (Figure 2). 
Moreover, not only the studied Mpro presented similarity 
to the others, but also the Glycoproteins Spike. 
Besides, two Non-structure Proteins (PDB: 6YHU and 
6WIQ) showed similarity, since they presented the 
same NSP7-NSP8 complex, whereas the other NSP 
presented several different complexes. In general, 
the similarity observed in the phylogenetic tree of 
the studied proteins classes is reflected in the binding 
energies.
Molecular docking 
The affinity between selected compounds and SARS-
CoV-2 proteins was observed in our study (Table 2). 
Nonetheless, chlorhexidine digluconate, catechin, and 
quercetin showed higher binding energy than others. 
A remarkable affinity between chlorhexidine and Mpro 
(PDB: 6Y84, -10.4 kcal/mol) was observed. Hydrogen 
peroxide showed to be the least recommended 
compound, since they presented the lowest affinity 
(-2.1 kcal/mol) with Spike glycoprotein (PBD: 6LVN) 
and Non-structure Protein (PDB: 6WIQ). The specific 
binding sites to each compound are shown in Figure 
3, in which we could observe that some compounds 




X Y Z X Y Z
6LU7 -26 13 59 126 126 126
6LVN 10 34 29 46 68 40
6VSB 206 223 227 104 92 126
6VXX 198 223 207 90 102 126
6VYB 197 223 206 126 102 126
6W4B 54 -11 23 56 68 54
6W4H 92 24 23 102 126 92
6W9C -32 34 26 126 126 126
6W37 -24 14 15 40 40 40
6WEY -2 5 13 126 90 122
6WIQ -4 -8 -6 96 100 114
6WJI 8 1 -14 126 100 96
6Y2E -17 -26 18 126 126 126
6Y84 12 1 5 72 84 90
6YB7 12 1 5 106 126 126
6YHU -25 25 51 70 100 114
Table 1- Grid parameters of SARS-CoV-2 proteins
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Interactions of the complex protein-ligand 
structure
The results of LigPlot+ analyses showed the 
interaction of chlorhexidine, catechin, and quercetin 
with Mpro or Non-structure Protein (Figure 4, Table 
3). Importantly, these compounds shared the same 
binding pocket in the Mpro (PDB: 6Y84).
Figure 1- Sequence alignment and multiple sequence comparisons of studied proteins from SARS-CoV-2
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Discussion
The null hypothesis was rejected, once the binding 
affinity among some compounds (chlorhexidine, 
catechin, and quercetin) and all proteins tested (Mpro, 
Spike glycoprotein, Papain-like protease, and Non-
structure Protein) was observed.
We constructed the phylogenetic tree of SARS-
CoV-2 proteins. We observe that the major proteins 
in the same group are similar. However, differences 
in the amino acid residues may affect the interaction 
between them and “external” molecules. Different 
affinity degrees were observed besides the similarity 
among the proteins in the same group. On the other 
hand, the non-structure protein (NSP) group shows a 
diversity in the presented complexes, explaining the 
different sequences and the binding energies among 
NSP.
The molecular docking showed the affinity of 
the tested compounds with SARS-CoV-2 proteins in 
different degrees. In our study, HP and PVPI presented 
the lowest affinities with SARS-CoV-2 proteins. 
However, HP and PVPI are reported in the literature 
as possible products to decrease the SARS-CoV-2 
salivary load in dental practice, due to their oxidative 
propriety.8,18 Thus, the obtained data allowed us to 
hypothesize that their mechanism of action against 
SARS-CoV-2 would not be binding-dependent. 
Other studies can also support this hypothesis, 
demonstrating the anti-SARS-CoV-2 effect of HP and 
PVPI solutions by in vitro studies19,20 and case report.21 
On the other hand, CHX was tested against SARS-
CoV-2, and the results evidenced better binding 
energies with all studied Mpro and papain-like protease. 
These SARS-CoV-2 proteases are the main targets of 
antiviral agents, since they play an essential role in 
viral RNA replication and controlling host cells.22 Thus, 
our experiments corroborate the data observed by 
Yoon, et al.23 (2020), allowing us to suggest that CHX 
may avoid the COVID-19 dissemination in the dental 
office. Additionally, QTN and CAT showed a remarkable 
affinity to Mpro, corroborating the previously published 
studies.24,25 All these compounds share the same 
binding pocket in the Mpro (PDB: 6Y84 – Lys5, Arg131, 
Lys137, Gly138, Asp289, Glu290). Thus, it allows us to 
suggest their activity against SARS-CoV-2 and possibly 
develop an effective treatment for COVID-19.
The spike glycoprotein was also studied in our 
work. The ability to bind to the ACE 2 makes the 
spike glycoprotein a crucial factor of pathogenicity.26,27 
Thus, according to Walls, et al.28 (2020), this group is 
an essential target to neutralize SARS-CoV-2. Based 
on this rationale, the scientific reports describe that 
the spike glycoprotein in an opened state (PDB: 
6VYB) would be associated with the most pathogenic 
coronaviruses. In contrast, the closed state is 




Binding Energy (ΔG – kcal/mol)
CHX CCP PVPI HP GA BCD CAT QTN
6LU7 -6.9 -4.2 -3.9 -2.8 -5.5 -5.9 -7.4 -7.5
6LVN -6.0 -3.6 -2.7 -2.1 -3.8 -4.0 -5.6 -4.8
6VSB -7.1 -4.6 -4.4 -3.4 -5.0 -5.5 -6.8 -6.4
6VXX -7.1 -4.5 -3.9 -3.5 -5.5 -6.0 -7.6 -7.2
6VYB -6.3 -4.3 -3.9 -3.1 -5.3 -5.9 -7.0 -8.5
6W4B -7.2 -4.3 -3.5 -2.5 -4.7 -4.8 -6.9 -6.7
6W4H -8.0 -4.9 -4.4 -3.5 -5.9 -7.2 -7.6 -8.6
6W9C -6.3 -4.7 -4.0 -2.9 -5.2 -5.7 -7.5 -6.6
6W37 -6.6 -3.8 -3.2 -2.5 -4.7 -4.6 -6.1 -6.5
6WEY -9.6 -4.3 -4.4 -3.4 -5.4 -6.1 -8.0 -8.4
6WIQ -5.1 -3.6 -3.1 -2.1 -3.6 -4.5 -4.6 -5.8
6WJI -7.4 -3.5 -3.9 -3.0 -4.8 -6.2 -7.2 -7.4
6Y2E -5.9 -3.6 -3.8 -2.9 -4.5 -6.1 -6.0 -7.2
6Y84 -10.4 -6.0 -4.5 -3.2 -6.9 -7.9 -9.1 -9.2
6YB7 -9.1 -5.1 -4.2 -3.4 -6.0 -7.1 -8.3 -8.2
6YHU -5.3 -3.4 -3.4 -2.5 -4.5 -5.0 -4.9 -5.4
CHX: chlorhexidine digluconate; CCP: cetylpyridinium chloride; 
PVPI: povidone-iodine; HP: hydrogen peroxide; GA: gallic acid; 
BCD: β-cyclodextrin; CAT: catechin; QTN:
Table 2- Binding energy between the tested compounds and the 
SARS-CoV-2 proteins
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associated with a common cold.28 In our study, both 
opened and closed spike glycoprotein had a binding 
affinity with CHX, CAT, and QTN, showing a possible 
transmissibility inhibition. However, CHX showed 
a more expressive binding energy, probably due 
to the four hydrogen bonds and eight hydrophobic 
interactions present in its molecule.
Based on our results, we hypothesized that 
chlorhexidine has two different action mechanisms 
against SARS-CoV-2: (i) acting on viral RNA replication 
and controlling host cells; and (ii) neutralizing spike 
glycoprotein, preventing the binding to the ACE-II. 
All these mechanisms may decrease pathogenicity in 
coronaviruses. 
Our study revealed the tested compounds’ 
affinity with SARS-CoV-2 proteins and suggested 
their effectiveness in preventing virus replication 
or entering the human cells. Thus, the evidence 
obtained from molecular docking analysis may guide 
the development of temporary protocols that can be 
used to prevent the contamination of dental workers 
by SARS-CoV-2 during dental procedures in COVID-19 
asymptomatic patients.
These findings suggest the possible mechanisms 
of action of the tested compounds that lead to the 
susceptibility of SARS-CoV-2. Nonetheless, in silico 
analysis provides preliminary data, which need to 
be addressed by in vitro and/or in vivo studies once 
in silico analysis present limitations such as: (i) the 
evidenced interactions by in silico analysis may not 
Figure 3- Binding complex and interaction visualization of tested compounds with SARS-CoV-2 proteins. Magenta: chlorhexidine 
digluconate; Green: cetylpyridinium chloride; Blue: povidone-iodine; Red: hydrogen peroxide; Cyan: gallic acid; Orange: β-cyclodextrin; 
Yellow: catechin; Pink: quercetin. Main protease - PDB: 6LU7 complex (a, b); Spike Glycoprotein – PDB: 6VYB complex (c, d); Non-
structure Protein – PDB: 6W4H complex (e, f); Papain-like Protease – PDB: 6W9C complex (g, h)
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Figure 4- Visualization of residue interactions. Chlorhexidine digluconate-Non structure protein (PDB: 6WEY) binding complex (a); 
Chlorhexidine digluconate-Mpro (PDB: 6YB7) binding complex (b); Cathechin- Mpro (PDB: 6Y84) binding complex (c); Quercetin- Mpro 
(PDB: 6Y84) binding complex (d), Chlorhexidine digluconate- Mpro (PDB: 6Y84) binding complex (e)
SETTE-DE-SOUZA PH, COSTA MJ, AMARAL-MACHADO L, ARAÚJO FA, ALMEIDA FILHO, LIMA LR
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Protein Ligand Interactions
6WEY CHX Hydrophobic interaction: Ser370(A), Phe372(A), Leu373(A), Glu374(A), Met375(A), Lys376(A), Ser377(A)
6YB7 CHX
Hydrogen bond: Arg131(A), Asp197(A), Met276(A), Ala285(A), Asp289(A)
Hydrophobic interaction: Thr199(A), Tyr237(A), Asn238(A), Tyr239(A), Leu272(A), Gly275(A), Leu286(A), Leu 
287(A)
6Y84
CAT Hydrogen bond: Lys5(A), Asp289(A)Hydrophobic interaction: Arg131(A), Lys137(A), Gly138(A), Glu290(A)
QTN Hydrogen bond: Lys5(A), Gln127(A), Asp289(A)Hydrophobic interaction: Arg131(A), Lys137(A), Gly138(A), Glu290(A)
CHX
Hydrogen bond: Lys5(A), Gln127(A), Thr199(A), Leu287(A)
Hydrophobic interaction: Arg131(A), Lys137(A), Gly138(A), Tyr239(A), Leu286(A), Glu288(A), Asp289(A), 
Glu290(A)
Table 3- Interaction between the compounds and the protein targets
CHX: chlorhexidine digluconate; CAT: catechin; QTN: quercetin.
mimic the in vivo interactions; (ii) the compound-
protein interaction may be purely physical, with no 
clinical significance; (iii) the lack of studies about the 
anti-SARS-CoV-2 activity of the studied compounds to 
discuss our findings better. On the other hand, some 
strengths should be emphasized: (i) it is the first report 
to suggest the mechanisms for CHX against SARS-
CoV-2; and (ii) we conducted a range of analyses to 
better understand the relationship between SARS-
CoV-2 proteins and some compounds used as mouth 
rinses.
Additionally, it is essential to emphasize that there 
are no scientific reports regarding effective drugs 
against SARS-CoV-2. However, our results may provide 
several usual data in screening useful therapeutic 
compounds, if further studied by in vitro and in vivo 
assays.
Conclusions
Finally, our findings suggest that chlorhexidine is 
the most active compound in reducing the SARS-CoV-2 
salivary load due to its better binding energy. It can be 
considered to be used as a mouthwash before dentistry 
procedures, reducing the SARS-CoV-2 contamination 
risk of dental workers. However, in vivo studies should 
be conducted to confirm their clinical use.
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